PeerVoice Oncology & Haematology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 19m. Bisher sind 258 Folge(n) erschienen. Dieser Podcast erscheint wöchentlich.

Gesamtlänge aller Episoden: 4 days 10 hours 39 minutes

subscribe
share






Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC


Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC


share








   24m
 
 

Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions


Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions


share








   20m
 
 

Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care


Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care


share








   55m
 
 

Question Time: Applying New Therapies for the Management of mTNBC


Question Time: Applying New Therapies for the Management of mTNBC


share








   38m
 
 

New Biomarkers, New Targets in Advanced NSCLC


New Biomarkers, New Targets in Advanced NSCLC


share








 2022-08-17  20m
 
 

Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias


Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias


share








 2022-08-01  18m
 
 

IAP Antagonists in Oncology: What Do We Know?


IAP Antagonists in Oncology: What Do We Know?


share








 2022-07-25  23m
 
 

Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC


Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC


share








 2022-07-11  37m
 
 

Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022


Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022


share








 2022-06-30  19m
 
 

Managing the Nuances of Paroxysmal Nocturnal Haemoglobinuria: Practical Strategies for Patients Receiving Complement Inhibitors


Managing the Nuances of Paroxysmal Nocturnal Haemoglobinuria: Practical Strategies for Patients Receiving Complement Inhibitors


share








 2022-05-26  21m